Model-Based Comparative Analysis of Rifampicin and Rifabutin Drug-Drug Interaction Profile

Autor: Vianney Tuloup, Mathilde France, Romain Garreau, Nathalie Bleyzac, Laurent Bourguignon, Michel Tod, Sylvain Goutelle

Publikováno v: Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 2021, 65 (9), pp.e0104321. ⟨10.1128/AAC.01043-21⟩
Antimicrob Agents Chemother

International audience; Rifamycins are widely used for treating mycobacterial and staphylococcal infections. Drug-drug interactions (DDI) caused by rifampicin (RIF) are a major issue. We used a model-based approach to predict the magnitude of DDI wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ed3da86cc060dc00ce2330db017a77a
https://hal.science/hal-03633663